4//SEC Filing
Chaya Moghrabi Dina 4
Accession 0001209191-20-055013
CIK 0001683553other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 12:14 PM ET
Size
12.7 KB
Accession
0001209191-20-055013
Insider Transaction Report
Form 4
Chaya Moghrabi Dina
Director
Transactions
- Purchase
Common Stock
2020-10-14$15.00/sh+250,000$3,750,000→ 2,161,022 total(indirect: See Footnotes) - Conversion
Common Stock
2020-10-14+1,911,022→ 1,911,022 total(indirect: See Footnotes) - Conversion
Series B Preferred Stock
2020-10-14−12,500,000→ 0 total(indirect: See Footnotes)→ Common Stock (1,911,022 underlying)
Footnotes (4)
- [F1]Each share of Series B Preferred Stock automatically converted into 0.152881822351322 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on October 14, 2020 (on an adjusted basis, after giving effect to the 1-for-6.541 reverse stock split of the common stock effected by the Issuer on October 2, 2020) The shares have no expiration date.
- [F2]Consists of 1,911,022 shares beneficially owned by Omega Fund VI, L.P.
- [F3]The Reporting Person, a Director of the Issuer, is an advisor at Omega Fund Management, LLC, an entity affiliated with Omega Fund VI, L.P. and disclaims beneficial ownership of the shares held by Omega Fund VI, L.P., except to the extent of her pecuniary interest therein.
- [F4]The shares were purchased in the Issuer's initial public offering.
Issuer
SPRUCE BIOSCIENCES, INC.
CIK 0001683553
Entity typeother
Related Parties
1- filerCIK 0001822418
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 12:14 PM ET
- Size
- 12.7 KB